Cita APA

Chumsri, S., Li, Z., Serie, D. J., Norton, N., Mashadi-Hossein, A., Tenner, K., & Saura Manich, C. (2022). Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.

Citación estilo Chicago

Chumsri, Saranya, Zhuo Li, Daniel J. Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner, y Cristina Saura Manich. Adaptive Immune Signature in HER2-positive Breast Cancer in NCCTG (Alliance) N9831 and NeoALTTO Trials. 2022.

Cita MLA

Chumsri, Saranya, et al. Adaptive Immune Signature in HER2-positive Breast Cancer in NCCTG (Alliance) N9831 and NeoALTTO Trials. 2022.